ARROWHEAD PHARMACEUTICALS IN (ARWR) Stock Income Statement
NASDAQ:ARWR • US04280A1007
Current stock price
56.71 USD
-0.86 (-1.49%)
At close:
56.7 USD
-0.01 (-0.02%)
Pre-Market:
| TTM (2025-12-31) | 2025 (2025-9-30) | 2024 (2024-9-30) | 2023 (2023-9-30) | 2022 (2022-9-30) | ||||
|---|---|---|---|---|---|---|---|---|
| Revenue | 1.09B | 829.45M | 3.55M | 240.70M | 243.20M | |||
| Minority Interest Expense | -31.31M | -31.75M | 10.20M | 4.00M | 400.00K | |||
| Operating Expenses | 790.41M | 731.10M | 604.63M | 445.70M | 421.70M | |||
| Research and Development | 612.00M | 574.78M | 478.18M | 332.00M | 281.20M | |||
| Selling, General, and Administrative Expenses | 153.33M | 132.40M | 107.86M | 101.30M | 130.10M | |||
| Operating Income | 300.57M | 98.35M | -601.08M | -205.00M | -178.50M | |||
| Interest Income/Expense | -50.84M | -52.07M | -9.63M | -3.00M | 5.00M | |||
| Other Income/Expense | 5.20M | 5.26M | -1.75M | 1.50M | 800.00K | |||
| Non Recurring Items | N/A | N/A | N/A | N/A | N/A | |||
| Income Before Taxes | 254.92M | 51.53M | -612.46M | -206.50M | -172.70M | |||
| Income Tax | 21.34M | 21.42M | -2.77M | 2.80M | 3.80M | |||
| Net Income | 202.26M | -1.63M | -599.49M | -205.30M | -176.10M | |||
| EBITDA | 325.65M | 122.27M | -582.49M | -192.50M | -168.10M | |||
| Per Share Data | ||||||||
| EPS Diluted Total Ops | 1.54 | -0.01 | -5.00 | -1.92 | -1.67 | |||
| Non GAAP EPS | 1.53 | -0.08 | -5.01 | -1.92 | -1.68 | |||
| Statistics | ||||||||
| Profit Margin | 18.54% | -0.20% | -16882.37% | -85.29% | -72.41% | |||
| Operating Profit Margin | 27.55% | 11.86% | -16927.06% | -85.17% | -73.40% | |||
All data in USD